212 related articles for article (PubMed ID: 33613429)
41. [Disease Characteristics, Treatment, and Prognosis of Chinese Patients with Autoimmune Encephalitis: A Retrospective Study].
Yang RN; Ge FF; Jiang JW; Wang Y; Zhang W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):142-148. PubMed ID: 35048615
[TBL] [Abstract][Full Text] [Related]
42. [Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis].
Hongzhi G; Weize K; Bin P; Yan H; Qiang L; Yuan J; Qing L; Hang S; Haitao R; Yicheng Z; Dawei S; Liying C
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(13):996-1001. PubMed ID: 26506710
[TBL] [Abstract][Full Text] [Related]
43. [Clinical approach and prognosis of continuous neurological care after intensive care for the patients with severe and refractory anti-N-methyl-D-aspartate receptor encephalitis].
Zhou SM; Guan HZ; Zhao MS; Huang FJ; Wei Y; Wang J; Liu JP; Zhao XL; Ren HT; Fan SY; Peng B; Qiao LY
Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1937-1941. PubMed ID: 32629592
[No Abstract] [Full Text] [Related]
44. Clinical Characteristics and Short-Term Prognosis of Children With Antibody-Mediated Autoimmune Encephalitis: A Single-Center Cohort Study.
Kang Q; Liao H; Yang L; Fang H; Hu W; Wu L
Front Pediatr; 2022; 10():880693. PubMed ID: 35874583
[TBL] [Abstract][Full Text] [Related]
45. Central Hypoventilation Is a Key Risk Factor for Mechanical Ventilation During the Acute Phase of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Xu Q; Wang Q; Han J; Mao F; Zeng S; Chen S; Zhao C; Gu M; Li Z; Fu X; Luo X; Huang Y
Front Neurol; 2021; 12():728594. PubMed ID: 34795627
[No Abstract] [Full Text] [Related]
46. [Anti-NMDA Receptor Antibody-Related Encephalitis].
Nagayama S; Tanaka K
Brain Nerve; 2016 Sep; 68(9):1001-1009. PubMed ID: 27667486
[TBL] [Abstract][Full Text] [Related]
47. Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis.
Shu Y; Chen C; Chen Y; Xu Y; Chang Y; Li R; Sun X; Peng L; Lu Z; Qiu W
Eur J Neurol; 2018 Jan; 25(1):178-184. PubMed ID: 29053906
[TBL] [Abstract][Full Text] [Related]
48. Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China.
Wang W; Li JM; Hu FY; Wang R; Hong Z; He L; Zhou D
Eur J Neurol; 2016 Mar; 23(3):621-9. PubMed ID: 26563553
[TBL] [Abstract][Full Text] [Related]
49. Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective/prospective cohort study.
Pruetarat N; Netbaramee W; Pattharathitikul S; Veeravigrom M
Brain Dev; 2019 May; 41(5):436-442. PubMed ID: 30639077
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for mortality in patients with anti-NMDA receptor encephalitis.
Chi X; Wang W; Huang C; Wu M; Zhang L; Li J; Zhou D
Acta Neurol Scand; 2017 Oct; 136(4):298-304. PubMed ID: 28028820
[TBL] [Abstract][Full Text] [Related]
51. [Clinical Manifestations and Complications in Patients with Anti-NMDA Receptor Encephalitis].
Yuan PQ; Li J; Zhang L; Li JM; Li YP; Yang R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 49(6):979-982. PubMed ID: 32677415
[TBL] [Abstract][Full Text] [Related]
52. Understanding Seizures and Prognosis of the Extreme Delta Brush Pattern in Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis: A Systematic Review.
Parwani J; Ortiz JF; Alli A; Lalwani A; Ruxmohan S; Tamton H; Cuenca VD; Gonzalez D; Anwer F; Eissa-Garcés A; Alzamora IM; Paez M
Cureus; 2021 Sep; 13(9):e18154. PubMed ID: 34589370
[TBL] [Abstract][Full Text] [Related]
53. Cerebrospinal Fluid Osteopontin and Inflammation-Associated Cytokines in Patients With Anti-
Zou C; Pei S; Yan W; Lu Q; Zhong X; Chen Q; Pan S; Wang Z; Wang H; Zheng D
Front Neurol; 2020; 11():519692. PubMed ID: 33250837
[TBL] [Abstract][Full Text] [Related]
54. [A comparative analysis of anti-N-methyl-D-aspartate receptor encephalitis with or without abnormal findings on cranial magnetic resonance imaging].
Zhang JZ; Chen Q; Zheng P; Xie LN; Yi XL; Ren HT; Yang J
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jan; 20(1):48-51. PubMed ID: 29335082
[TBL] [Abstract][Full Text] [Related]
55. Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis.
Byun JI; Lee ST; Moon J; Jung KH; Shin JW; Sunwoo JS; Lim JA; Shin YW; Kim TJ; Lee KJ; Park KI; Jung KY; Lee SK; Chu K
Auton Neurosci; 2015 Dec; 193():142-6. PubMed ID: 26275576
[TBL] [Abstract][Full Text] [Related]
56. Relapse factors of patients of anti-N-methyl-D-aspartate receptor encephalitis.
Zhao YY; Wang HX; Wang M; Yuan B; Sun TW; Xu YM
Acta Neurol Scand; 2022 Apr; 145(4):434-441. PubMed ID: 34927233
[TBL] [Abstract][Full Text] [Related]
57. A young child of anti-NMDA receptor encephalitis presenting with epilepsia partialis continua: the first pediatric case in Korea.
Kim EH; Kim YJ; Ko TS; Yum MS; Lee JH
Korean J Pediatr; 2016 Nov; 59(Suppl 1):S133-S138. PubMed ID: 28018466
[TBL] [Abstract][Full Text] [Related]
58. [Analysis of clinical characteristics and outcomes of mechanically ventilated patients with anti-N-methyl-D-aspartate receptor encephalitis].
Zhang Y; Su YY; Gao DQ; Ye H
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):187-192. PubMed ID: 28162168
[No Abstract] [Full Text] [Related]
59. First reported cases of anti-NMDA receptor encephalitis in Vietnamese adolescents and adults.
Nguyen Thi Hoang M; Nguyen Hoan P; Le Van T; McBride A; Ho Dang Trung N; Tran Tan T; Nguyen Thi Thu H; Heemskerk D; Day J; Vincent A; Nguyen Van Vinh C; Thwaites G
J Neurol Sci; 2017 Feb; 373():250-253. PubMed ID: 28131199
[TBL] [Abstract][Full Text] [Related]
60. Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis.
Wang H; Xiao Z
Biomed Res Int; 2020; 2020():7506590. PubMed ID: 32352007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
